Clinical Trial Update: A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Medium to High Risk Myelofibrosis [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating Flonoltinib Maleate Tablets in patients with medium to high-risk myelofibrosis who are refractory/relapsed/intoleran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Flonoltinib Maleate Tablets (Flonoltinib maleate)

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: MF | Phase 2 | Status: RECRUITING